Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma

American Journal of Hematology

Volumn 52, Issue 4, 1996, Pages 275-280

  Avilés, Agustin ^a   Guzmán, Renaldo ^a   Delgado, Serafin ^a   Nambo, M Jesús ^a   Garcí́a, Edna L ^a   Díaz Maqueo, José C ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

bone marrow transplantation; epirubicin; etoposide; hematopoietic growth factors; ifosfamide; malignant lymphoma; radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPIRUBICIN; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; IFOSFAMIDE; LYMPHOMA; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0029737919     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199608)52:4<275::AID-AJH6>3.0.CO;2-P     Document Type: Article

References (28)

1. Salles G, Shipp M, Coiffier B: Chemotherapy of non-Hodgkin's aggressive lymphoma. Semin Oncol 31:46, 1984.
2. Fisher RI, Gaynor ER, Dahlberg S, et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1124, 1993.
3. Epelbaum R, Faraggi D, Ben-Arie Y, et al.: Survival of diffuse large cell lymphoma. Cancer 66:1124, 1990.
4. Meyer RM, Hryniuk WH, Goodyear MDE: The use of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma. J Clin Oncol 9:339, 1991.
5. McMaster ML, Greer JP, Wolff SN, et al.: Results of treatment with high-intensity brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma. Cancer 68:233, 1991.
6. Sweetenham JW, Mead GM, Whitehouse JMF: Intensive weekly combination chemotherapy for patients with intermediate grade and high-grade non-Hodgkin's lymphoma. J Clin Oncol 9:2202, 1991.
7. Waits TM, Greco FA, Greer JP, Hainsworth JP: Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration. Long term follow-up. Leuk Lymph 10:453, 1993.
8. Zuckerman KS, Lobuglio AF, Reeves JA: Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphoma with a high-dose doxorubicin containing regimen. J Clin Oncol 8:248, 1990.
9. Zuckerman KS, Case AC, Gams RA, Prastofer EF: Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphoma with an intensive epirubicin containing regimen. Blood 82:3564, 1993.
10. Tarosaki R, Okamoto S, Akatsuka N, et al.: Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma. Cancer 74:1939, 1994.
11. Gerhartz HH, Engelhard M, Meusers P, et al.: Randomized double-blind, placebo-controlled phase III study of recombinant human granulocyte-macrophage colony stimulating factor as adjuvant induction treatment of high-grade malignant lymphoma. Blood 82:2329, 1993.
12. Avilés A, Díaz-Maqueo JC, Talavera A, Nambo MJ, García EL: Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy. Leuk Lymph 15:1531, 1994.
13. Walther J, Wilmanns W, Gerhartz HH: IEVM chemotherapy with rHGM CSF support for aggressive non-Hodgkin's lymphoma. A pilot study. Ann Hematol 66:135, 1993.
14. The International Non-Hodgkin's Lymphoma Prognostic Factor Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993.
15. Avilés A, Delgado S, Nambo MJ, Alatriste S, Díaz-Maqueo JC: Adjuvant radiotherapy to site of previous bulky disease in patients with stage IV diffuse large cell lymphoma. Int J Radiat Oncol Biol Phys 30:799, 1994.
16. Avilés A, Nambo MJ, Talavera A, et al.: GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma. Leuk Lymph 17:327, 1995.
17. Avilés A, Férnandez R, Talavera A, Guzmán R: The role of G-CSF as hematological support after myeloablative chemotherapy for refractory Hodgkin's disease. Cancer Res Ther Control 4:241, 1995.
18. Non-Hodgkin's Lymphoma Classification Project. National Cancer Institute sponsored study classification of non-Hodgkin's lymphoma. Cancer 49:2112, 1992.
19. Kaplan EL, Meier EL: Non parametric estimations from incomplete observations. J Am Stat Assoc 53:457, 1958.
20. Avilés A, Huerta J, Guzmán R, et al.: CHOP-Bleo versus M-BACOD en el tratamiento de linfomas malignos de grado intermedio y alto de malignidad. Rev Invest Clin 42:271, 1990.
21. Avilés A, Díaz-Maqueo JC, Torras V, Rodriguez L, López-VancellD: Linformas no hodgkinianos. Resultados de la quimioterapia alterna frente a la quimioterapia secuencial Sangre (Bare) 35:245, 1990.
22. Shipp MA, Shulman LN, Kaplan WD, Neuberg D, Canellos GP: Intensified induction therapy for patients with "high-risk" aggressive NHL. High dose CHOP. Blood 83(Suppl 1):332a (abstract).
23. Gianni AM, Bregni M, Siena P, et al.: Five-year update of the Milan Cancer Institute randomised trial of high dose sequential (HDS) vs. MACOP-B therapy for diffuse large cell lymphoma. Proc Am Soc Clin Oncol 13:373, 1994 (abstract).
24. Haouin C, Lepage E, Gisselbrecht C, et al.: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate- and high-grade non-Hodgkin's lymphoma in first remission. A study of 464 patients. J Clin Oncol 12:2543, 1994.
25. Verdonck L, van Putten LJ, Hagenbeek A, et al.: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding chemotherapy patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332:1043, 1995.
26. Mizra MR, Brickner H, Specht L: The integration of radiotherapy into the primary treatment of non-Hodgkin's lymphoma. Crit Rev Oncol Hematol 12:217, 1992.
27. Shafman TD, Mauch PM: The large cell lymphomas. Sem Radiat Ther 5:267-280, 1995
28. Glick JH, Kim K, Earle J, et al.: An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL). Proc Am Soc Clin Oncol 14:391, 1995 (abstract).